Aclarion, Inc. (ACON) Stock Ticker
Market factors today
Unlock the full ACON picture
About Aclarion, Inc.
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.
ACON stock facts
| Ticker symbol | ACON |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
| Market cap | $1.4M |
| CEO | Brent Ness |
| Employees | 11 |
| Headquarters | Broomfield, CA, US |
| IPO date | 2022-04-22 |
| Website | www.aclarion.com |
What you can see for ACON on Tickr
Live ACON price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ACON report.
Rankings
FAQ
What is the ticker symbol for Aclarion, Inc.?
The ticker symbol for Aclarion, Inc. is ACON, listed on the NASDAQ Capital Market.
What is ACON?
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to…